Team BIO

In 2024, BIO experienced some important changes that set the stage for its next phase of growth and impact. The Executive Committee saw key leadership transitions. After the outstanding service of his predecessor, Luuk Zonneveld—who was honoured by His Majesty the King with the Order of the Crown for his contributions—Joris Totté took over as CEO, bringing his expertise and vision to lead BIO forward. At the same time, Tine Vlietinck stepped into the role of Chief Corporate Officer, with a focus on shaping BIO's strategy and growth. The search for a new Chief Financial Officer began in 2024 and was successfully completed with the appointment of Rebecca Scheps in early 2025, strengthening BIO's financial leadership.

There were also changes in BIO's liaison offices, which are key to engaging locally and building partnerships. In the East Africa Office, Alexis Losseau handed over the reins to Nada Shall, who will continue to receive valuable support from Pearl Nyaosi to maintain BIO's strong relationships in the region. In Abidjan, Maximilien d'Harcourt passed the baton to Gilles Dossogne, who will be supported by Dorian Zohou to keep BIO’s presence strong in West Africa.

Another notable change took place within the SDG Frontier Fund (SDG FF), one of BIO's key investment tools. Eric Van den Bosch, who was instrumental in establishing the fund, was succeeded by Maximilien d'Harcourt, who will now lead the fund into its next phase.